A new European study has been launched


For the first time in history, the European Union has financially supported a clinical trial of psychedelic therapy that will take place from 2025 in several locations, including the Czech Republic. The PsyPal clinical trial will look at the safety and effect of psilocybin-assisted psychotherapy on depression and anxiety in palliative care patients. A full recording of the EP event can be found here.

For more info visit parea.eu.